Loading…
SARMs Control Act of 2019
Legislative Progress
Introduced
November 19, 2019
Latest Action
November 19, 2019
Primary Sponsor
Chuck GrassleyRepublican(IA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,086 other S bills in the 116th — cohort avg 30d
Selective Androgen Receptor Modulators Control Act of 2019 or the SARMs Control Act of 2019 This bill expands the federal regulatory framework for drugs that are deemed to pose a risk of abuse and dependence to address selective androgen receptor modulators. These are synthetic drugs or substances that have effects similar to testosterone.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2020 · fourth_quarter · Consumer Issues/Safety/Products
Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020. H.R. 5587 - A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances. S. 2895 - SARMs Control Act of 2019, A bill that would give authority to the Attorney General to schedule SARMs as a controlled substance.
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $60,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of
2020 · fourth_quarter · Food Industry (safety, labeling, etc.)
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5587 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client expense: $146,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, Vice President of the U.S.
2020 · third_quarter · Consumer Issues/Safety/Products
Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020. H.R. 5587 - A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances. S. 2895 - SARMs Control Act of 2019, A bill that would give authority to the Attorney General to schedule SARMs as a controlled substance.
Client expense: $70,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of
2020 · third_quarter · Food Industry (safety, labeling, etc.)
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5587 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client expense: $140,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, Vice President of the U.S.
2020 · second_quarter · Consumer Issues/Safety/Products
Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 5587 - A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances. S. 2895 - SARMs Control Act of 2019, A bill that would give authority to the Attorney General to schedule SARMs as a controlled substance.
Client expense: $70,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
2020 · second_quarter · Food Industry (safety, labeling, etc.)
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5587 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client expense: $128,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, Vice President of the U.S.
2020 · first_quarter · Consumer Issues/Safety/Products
Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. S. 2895 - SARMs Control Act of 2019, A bill that would give authority to the Attorney General to schedule SARMs as a controlled substance.
Client expense: $70,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
2020 · first_quarter · Food Industry (safety, labeling, etc.)
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5587 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Client expense: $165,000 · Firm income: Not reported
2019 · fourth_quarter · Consumer Issues/Safety/Products
Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. S. 2895 - SARMs Control Act of 2019, A bill that would give authority to the Attorney General to schedule SARMs as a controlled substance.
Client expense: $60,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Food Industry (safety, labeling, etc.)
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020
Client expense: $177,500 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of